Literature DB >> 8880614

Pediatric Devic's neuromyelitis optica.

A R Jeffery1, J R Buncic.   

Abstract

PURPOSE: Neuromyelitis optica (Devic's disease) is a rare clinical syndrome of unilateral or bilateral optic neuritis (ON) and transverse myelitis (TM) occurring within an 8-week time interval. All reports mainly involve adults and describe a poor neurologic and ophthalmic clinical course without specific attention to their few pediatric cases. The purpose of this study was to develop a clinical profile in the pediatric population.
METHODS: A retrospective chart review over 15 years revealed nine cases of neuromyelitis optica. A literature search was undertaken and all cases of pediatric neuromyelitis optica were tabulated and analyzed separately.
RESULTS: The average age of onset was 7 years with a preceding viral prodrome in all patients. The optic neuritis was bilateral in eight of nine patients (89%). Visual loss ranged from 20/30 to light perception. Moderate anterior disc edema was seen in all 17 affected eyes. The clinical course was characterized by a rapid visual and neurologic recovery. The average follow up was 5.3 years, with five patients followed for 6 years or longer. None of the nine patients had any visual or neurologic recurrence or other significant subsequent illness. Visual system follow up showed 20/20 in each eye of all patients with mild optic atrophy, identified in 47% of eyes.
CONCLUSIONS: Devic's neuromyelitis optica occurs in the pediatric population as a distinct clinical entity with an excellent prognosis for visual and systemic recovery and no future recurrence or long-term sequelae.

Entities:  

Mesh:

Year:  1996        PMID: 8880614     DOI: 10.3928/0191-3913-19960901-05

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN: 0191-3913            Impact factor:   1.402


  9 in total

1.  Protective environmental factors for neuromyelitis optica.

Authors:  Jennifer Graves; Siri Grandhe; Kelley Weinfurtner; Lauren Krupp; Anita Belman; Tanuja Chitnis; Jayne Ness; Bianca Weinstock-Guttman; Mark Gorman; Marc Patterson; Moses Rodriguez; Tim Lotze; Gregory Aaen; Ellen M Mowry; John W Rose; Timothy Simmons; T Charles Casper; Judith James; Emmanuelle Waubant
Journal:  Neurology       Date:  2014-10-22       Impact factor: 9.910

2.  Neuromyelitis optica immunoglobulin G in a child.

Authors:  Lynsee A Hudson; Timothy J Bernard; Brian S Tseng; Bradford R Miller; John R Corboy
Journal:  Pediatr Neurol       Date:  2006-11       Impact factor: 3.372

3.  Neuromyelitis optica in a young child with positive serum autoantibody.

Authors:  Ingrid P Loma; Miya R Asato; Robyn A Filipink; Gulay Alper
Journal:  Pediatr Neurol       Date:  2008-09       Impact factor: 3.372

4.  Treatment of pediatric optic neuritis.

Authors:  Gabrielle R Bonhomme; Ellen B Mitchell
Journal:  Curr Treat Options Neurol       Date:  2012-02       Impact factor: 3.972

5.  Idiopathic transverse myelitis and neuromyelitis optica: clinical profiles, pathophysiology and therapeutic choices.

Authors:  Amer Awad; Olaf Stüve
Journal:  Curr Neuropharmacol       Date:  2011-09       Impact factor: 7.363

6.  Assessment of Optic Nerve Impairment in Patients with Neuromyelitis Optica by MR Diffusion Tensor Imaging.

Authors:  Zhiye Chen; Xin Lou; Mengqi Liu; Dehui Huang; Shihui Wei; Shengyuan Yu; Lin Ma
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

7.  Neuromyelitis optica in child: diagnostic and therapeutic challenges.

Authors:  Karolina Dembinski; Maria Gieron-Korthals; Carlos R Martinez; Lisa Rodriguez
Journal:  Case Rep Pediatr       Date:  2013-12-11

8.  Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report.

Authors:  Tanuja Chitnis; Jayne Ness; Lauren Krupp; Emmanuelle Waubant; Tyler Hunt; Cody S Olsen; Moses Rodriguez; Tim Lotze; Mark Gorman; Leslie Benson; Anita Belman; Bianca Weinstock-Guttman; Greg Aaen; Jennifer Graves; Marc Patterson; John W Rose; T Charles Casper
Journal:  Neurology       Date:  2015-12-18       Impact factor: 9.910

9.  Abnormal Baseline Brain Activity in Neuromyelitis Optica Patients Without Brain Lesion Detected by Resting-State Functional Magnetic Resonance Imaging.

Authors:  Yi Liu; Hua Xiong; Xiaojiao Li; Dan Zhang; Chao Yang; Jiayi Yu; Ruikun Liao; Bi Zhou; Xianlong Huang; Zhuoyue Tang
Journal:  Neuropsychiatr Dis Treat       Date:  2020-01-08       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.